- Exelixis Announces U.S. FDA Accepts for Priority Review the Supplemental New Drug Application for CABOMETYX® (cabozantinib) for Patients with Previously Treated Radioactive Iodine-Refractory Differentiated Thyroid Cancer
- 2019 CLASSIC COVERAGE: 'DON'T TELL BOBBY' EATON TRIBUTE SEGMENT
- McKinney Chamber Of Commerce - Blog: Ambassador Spotlight - Jeff Shoemake
- Worldwide Kidney Cancer Diagnostics and Therapeutics Industry to 2026 - Endorsement of Novel Drugs for Treatment is Driving Growth - ResearchAndMarkets.com
- Does Medicare Cover Colonoscopy?
- Community Bulletin Board
- American Cancer Society Planning Two Events in Sartell
- Moderate consumption of alcohol strongly linked to several cancers, including bowel cancer
- Global Kidney Cancer Diagnostics and Therapeutics Market (2020 to 2026) - Featuring Abbvie, Active Biotech and AstraZeneca Among Others
- A thank you from Times-Journal staff
- Annual Farm To Table Metro East Will Continue To-go Format To Help Save Lives From Cancer
- Innovation In Breast Cancer Research Saving Lives Through Genetic Detection | JD Supra
- The business of giving
- Worldwide Kidney Cancer Diagnostics and Therapeutics Industry to 2026 - Endorsement of Novel Drugs for Treatment is Driving Growth - ResearchAndMarkets.com
- Exelixis Announces U.S. FDA Accepts for Priority Review the Supplemental New Drug Application for CABOMETYX® (cabozantinib) for Patients with Previously Treated Radioactive Iodine-Refractory Differentiated Thyroid Cancer
When you include the American Institute for Cancer Research in your estate plans, you make a major difference in the fight against cancer.
Corporate Champions who partner with the American Institute for Cancer Research stand at the forefront of the fight against cancer
The Continuous Update Project (CUP) is an ongoing program that analyzes global research on how diet, nutrition and physical activity affect cancer risk and survival.
A major milestone in cancer research, the Third Expert Report analyzes and synthesizes the evidence gathered in CUP reports and serves as a vital resource for anyone interested in preventing cancer.
Whether you are a healthcare provider, a researcher, or just someone who wants to learn more about cancer prevention, we’re here to help.
AICR has pushed research to new heights, and has helped thousands of communities better understand the intersection of lifestyle, nutrition, and cancer.
Read real-life accounts of how AICR is changing lives through cancer prevention and survivorship.
We bring a detailed policy framework to our advocacy efforts, and provide lawmakers with the scientific evidence they need to achieve our objectives.
AICR champions research that increases understanding of the relationship between nutrition, lifestyle, and cancer.
AICR’s resources can help you navigate questions about nutrition and lifestyle, and empower you to advocate for your health.
AICR is committed to putting what we know about cancer prevention into action. To help you live healthier, we’ve taken the latest research and made 10 Cancer Prevention Recommendations.
